Valuations and Business Models for Biotechnology Companies. The primary aim of this project is to reduce the risk involved in investment in biotechnology companies by developing a model that will aid in a more accurate assessment of their value. This project will also develop commercialisation pathways incorporating valuation modeling techniques that will maximise the commercial potential of the intellectual capital portfolios held by biotechnology companies. By developing new models that accoun ....Valuations and Business Models for Biotechnology Companies. The primary aim of this project is to reduce the risk involved in investment in biotechnology companies by developing a model that will aid in a more accurate assessment of their value. This project will also develop commercialisation pathways incorporating valuation modeling techniques that will maximise the commercial potential of the intellectual capital portfolios held by biotechnology companies. By developing new models that account for the specific variables of the biotechnology industry, this project will contribute new knowledge and advance development of valuation models applicable to other knowledge-based industries which share characteristics such as intangible assets, high risk, complexity and uncertainty.Read moreRead less
Valuations and Business Models for Biotechnology Companies. The primary aim of this project is to reduce the risk involved in investment in biotechnology companies by developing a model that will aid in a more accurate assessment of their value. This project will also develop commercialisation pathways incorporating valuation modeling techniques that will maximise the commercial potential of the intellectual capital portfolios held by biotechnology companies. By developing new models that accoun ....Valuations and Business Models for Biotechnology Companies. The primary aim of this project is to reduce the risk involved in investment in biotechnology companies by developing a model that will aid in a more accurate assessment of their value. This project will also develop commercialisation pathways incorporating valuation modeling techniques that will maximise the commercial potential of the intellectual capital portfolios held by biotechnology companies. By developing new models that account for the specific variables of the biotechnology industry, this project will contribute new knowledge and advance development of valuation models applicable to other knowledge-based industries which share characteristics such as intangible assets, high risk, complexity and uncertainty.Read moreRead less